278 related articles for article (PubMed ID: 1411908)
1. Immunological mechanisms involved in psoriasis.
Griffiths CE; Voorhees JJ
Springer Semin Immunopathol; 1992; 13(3-4):441-54. PubMed ID: 1411908
[No Abstract] [Full Text] [Related]
2. The pathogenesis of psoriasis: immunological facts and speculations.
Bos JD; De Rie MA
Immunol Today; 1999 Jan; 20(1):40-6. PubMed ID: 10081229
[No Abstract] [Full Text] [Related]
3. Activated keratinocytes present bacterial-derived superantigens to T lymphocytes: relevance to psoriasis.
Nickoloff BJ; Mitra RS; Green J; Shimizu Y; Thompson C; Turka LA
J Dermatol Sci; 1993 Oct; 6(2):127-33. PubMed ID: 8274458
[TBL] [Abstract][Full Text] [Related]
4. [Immunology in clinical practice. VII. Psoriasis].
Bos JD; de Rie MA
Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2334-8. PubMed ID: 9550823
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and immunointervention strategies for psoriasis. IBC's Inflammatory Skin Disorders. Washington, DC, USA. September 17-18, 1998.
Nickoloff BJ
Mol Med Today; 1998 Dec; 4(12):512-3. PubMed ID: 9866819
[No Abstract] [Full Text] [Related]
6. The immunology of psoriasis and biologic immunotherapy.
Mehlis SL; Gordon KB
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S44-50. PubMed ID: 12894125
[TBL] [Abstract][Full Text] [Related]
7. Targeting leukocyte recruitment in the treatment of psoriasis.
Li YY; Zollner TM; Schön MP
Clin Dermatol; 2008; 26(5):527-38. PubMed ID: 18755372
[TBL] [Abstract][Full Text] [Related]
8. Novel biological immunotherapies for psoriasis.
Kanitakis J; Butnaru AC; Claudy A
Expert Opin Investig Drugs; 2003 Jul; 12(7):1111-21. PubMed ID: 12831347
[TBL] [Abstract][Full Text] [Related]
9. [Psoriasis: pathogenesis and treatment].
Heenen M
Rev Med Brux; 2003 Jun; 24(3):139-47. PubMed ID: 12891880
[TBL] [Abstract][Full Text] [Related]
10. Putting together the psoriasis puzzle: an update on developing targeted therapies.
Johnson-Huang LM; Lowes MA; Krueger JG
Dis Model Mech; 2012 Jul; 5(4):423-33. PubMed ID: 22730473
[TBL] [Abstract][Full Text] [Related]
11. The Immunogenetics of Psoriasis and Implications for Drug Repositioning.
Xu X; Zhang HY
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292715
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis and the new biologic agents: interrupting a T-AP dance.
Walsh SR; Shear NH
CMAJ; 2004 Jun; 170(13):1933-41. PubMed ID: 15210644
[TBL] [Abstract][Full Text] [Related]
13. Adhesion molecules in keratinocytes.
Čabrijan L; Lipozenčić J
Clin Dermatol; 2011; 29(4):427-31. PubMed ID: 21679870
[TBL] [Abstract][Full Text] [Related]
14. Novel immunotherapies for psoriasis.
Asadullah K; Volk HD; Sterry W
Trends Immunol; 2002 Jan; 23(1):47-53. PubMed ID: 11801454
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of psoriasis].
Schäkel K; Schön MP; Ghoreschi K
Hautarzt; 2016 Jun; 67(6):422-31. PubMed ID: 27246016
[TBL] [Abstract][Full Text] [Related]
16. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
Albanesi C; De Pità O; Girolomoni G
Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
[TBL] [Abstract][Full Text] [Related]
17. Psoriasis. Leukocytes and cytokines.
Cooper KD
Dermatol Clin; 1990 Oct; 8(4):737-45. PubMed ID: 2249364
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms of action of cyclosporin A in the treatment of psoriasis.
Wong RL; Winslow CM; Cooper KD
Immunol Today; 1993 Feb; 14(2):69-74. PubMed ID: 8447934
[TBL] [Abstract][Full Text] [Related]
19. Role of adhesion molecules in activation signaling in T lymphocytes.
Dustin ML
J Clin Immunol; 2001 Jul; 21(4):258-63. PubMed ID: 11506195
[TBL] [Abstract][Full Text] [Related]
20. Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology.
Kimball AB; Kupper TS
Clin Dermatol; 2008; 26(5):554-61. PubMed ID: 18755375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
